RankingsPricing
  1. JP-listed companies
  2. StemCell Institute Inc.
  3. Financials
  4. Earnings per share

StemCell Institute Inc.JP:7096

Market cap
¥8.1B
P/E ratio
25.1x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 202537.7+24.12%
Mar 31, 202430.4+57.01%
Mar 31, 202319.3-26.81%
Mar 31, 202226.4+106.17%
Mar 31, 202112.8-77.53%
Mar 31, 202057+94.24%
Mar 31, 201929.4-99.71%
Mar 31, 201810,002.6-35.51%
Mar 31, 201715,510-9.63%
Mar 31, 201617,162.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)